Search PubMed⌕ Search

Biomedical subjects

S L White

Publications and source records attributed to S L White.

At least 55 records · Page 3Linked to original sources
PubMed1995

Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.

Topical cyclosporine A was safely used in a series of 11 cases of equine keratitis and keratouveitis and appeared to be an effective anti-inflammatory agent in 9 cases. The clinical diagnoses included interstitial keratouveitis, endotheliitis, multifocal punctate keratopathy and a melting stromal ulcer. In most cases, the presence or absence of insidious bacterial infection was not conclusively determined. Topical cyclosporine A had no deleterious effects in this series of cases. The authors suggest that topical cyclosporine in both aqueous and lipid base vehicles should be investigated and evaluated as an alternative mode of achieving ocular immunosuppression.

Administration, Topical↗
PubMed1995

Heart rate response and plasma lactate concentrations of horses competing in the cross-country phase of combined training events.

The exercise intensity of horses (n = 175) competing in the cross-country phase of 4 combined training events at 5 levels of competition [novice (N), training (T), preliminary (P), intermediate (I) and advanced (A)] was investigated. Environmental conditions varied from cool and humid (mean +/- s.d. temperature and humidity = 12.1 degrees C +/- 0.6 and 88.4% +/- 8.9 RH) to moderately hot and humid (27.8 degrees C +/- 2.1 and 62.5% +/- 7.8 RH). Heart rates (beats/min) were recorded continuously at 5 s intervals with a heart monitor. Mean +/- s.d. heart rates (beats/min) for each level of competition were: 154.4 +/- 19.2 beats/min (n = 45) (N), 160.4 +/- 28.1 beats/min (n = 47) (T), 160.6 +/- 33 beats/min (n = 53) (P), 181 +/- 26.6 beats/min (n = 29) (I) and 194.6 +/- 4.2 beats/min (n = 4) (A). Plasma lactate concentration was determined at rest in a random sampling of horses (n = 36) from all competitions and within 60 s of completion of the cross-country phase in all horses. Mean +/- s.d. lactate concentration at rest was 0.98 +/- 0.3 mmol/l. Mean +/- s.d. lactate concentrations (mmol/l) of horses after exercise were: N = 8.1 +/- 7, T = 11.5 +/- 4.7, P = 17.6 +/- 6.1, I = 19 +/- 6.7 and A = 21.3 +/- 7.3. Mean plasma lactate increased significantly (P < 0.001) as levels of competition increased, although there were few significant differences in heart rate between levels. Rectal temperatures were taken immediately after completion of the cross-country phase and 10 min later. Mean +/- s.d. rectal temperatures were significantly higher 10 min after completion of the cross-country than those taken immediately after cross-country (P < 0.001). Rectal temperatures 10 min after completion of exercise were significantly higher as the level of competition increased for N through I (P < 0.001). Rectal temperatures 10 min after completion of exercise were correlated with ambient temperatures (r = 0.22, P = 0.01). There was no significant correlation between either pulse or respiratory rate taken immediately after completion of exercise with heart rate during the course.

Analysis of Variance↗
PubMed1995

Heart rate response and plasma lactate concentrations of horses competing in the speed and endurance phase of 3-day combined training events.

The exercise intensity of horses competing in 3-day combined training events at 3 different levels of competition (CCI, n = 7; CCI, n = 11; CCI, n = 23) was investigated. Environmental conditions during all events were cool with 100% cloud cover. Heart rates were continuously recorded at 5 s intervals by a heart rate monitor. Mean +/- s.d. heart rate for all horses during each phase were: Phase A = 118 +/- 11 beats/min, Phase B = 179 +/- 22.7 beats/min, Phase C = 129 +/- 13.9 beats/min and Phase D = 174 +/- 19.6 beats/min. Mean +/- s.d. heart rates on Phase A and C were significantly different from mean heart rates on Phases B and D. Plasma lactate concentrations were determined at rest, within 60 s and 10 min after the end of Phase D or the cross country test. Mean +/- s.d. lactate concentrations were highest immediately post exercise (mean = 18.4 +/- 5 mmol/l for all horses) and had declined significantly in 10 min (mean = 15 +/- 6.8 mmol/l for all horses). Mean +/- s.d. heart rates and lactate concentrations were not significantly different among levels of competition at each time period. The intensity of work of fit horses successfully competing in 3-day combined training events consists of both low intensity aerobic exercise and more intense submaximal work with significant anaerobiosis. The work intensity is remarkably constant throughout different levels of competition, despite the increasing distance, number and difficulty of jumping efforts and faster optimum speeds.

Analysis of Variance↗
PubMed1995

Haematological and biochemical changes in horses competing in a 3 Star horse trial and 3-day-event.

Haematological and biochemical changes in horses competing in the Endurance Test (Phase T and D) of an advanced Horse Trial (HT, n = 22) and the Endurance Test (Phases A-D) of an advanced (CCI) 3-day-event (TD, n = 11) over a similar course on the same day were studied. Environmental conditions during the event were cool (5.5-11.1 degrees C). Blood samples were collected from the horses in each group the evening prior to the Endurance Test, within 60 s after, and 10 min after, completion of Phase D (cross-country jumping). The following were determined in the blood samples and compared between the 2 groups of horses: packed cell volume (PCV), serum total protein [TP], serum albumin [ALB], plasma lactate [lactate], serum total calcium [TCa], plasma ionised calcium [Ca+2], serum inorganic phosphate [PO4], plasma pH, plasma sodium [Na], plasma potassium [K], serum chloride [Cl], serum urea nitrogen [SUN], serum creatinine [Cr] and serum glucose concentrations and aspartate aminotransferase (AST) and creatine kinase (CK) activities. The PCV and [Cr] were higher in the TD group and approached significance (P = 0.063 and P = 0.057, respectively). The [TP], [ALB], [Na], glucose concentration and CK, and AST were significantly higher and [Cl] and [PO4] were significantly lower in the TD group after exercise when compared to the HT group. It was deduced from these data that the horses competing in the 3-day-event experienced greater fluid and electrolyte losses, reduced glomerular filtration, higher glycogenolysis and had greater leakage of enzymes from working muscles during competition than horses competing in the horse trial.

Animals↗
PubMed1995

Effects of shortening the steeplechase phase (phase B) of a 3-day-event.

Thirty-four horses competing in the Endurance Test of a 3-day-event were divided into 3 groups: horses in Group 1 (n = 15) competing in a 3.5 min steeplechase phase; horses in Group 2 (n = 13) in a 3 min steeplechase phase (Phase B) and horses in Group 3 (n = 6) in a 2.5 min steeplechase phase. The shortening of Phase B was associated with a lengthening of Phase C so that the total distance of the event for all horses was 14,940 m. Bodyweight (BW) was measured and total body water (TBW) and water loss estimated. Blood samples were collected from the horses prior to the Endurance Test, at the end of Phase B, the 4 km marker on Phase C (C4K), the end of Phase C, and 20 min after the completion of Phase D for measurement of packed cell volume (PCV), total plasma protein [TPP], lactate, ionised calcium, pH, sodium, potassium, chloride, total calcium and glucose concentrations, and aspartate aminotransferase, creatine kinase and lactate dehydrogenase activities. Mean +/- s.d. ambient environmental temperature during the Endurance Test was 25.3 +/- 1 degrees C (range 20.3 degrees C-29.7 degrees C). Mean relative humidity was 43.8 +/- 2.4% (range 39%-48.6%) and the average 'comfort index' (CI) was 121. There were no significant differences between the groups competing in the Endurance Test, despite the shorter Phase B. However, there were significant decreases in BW, TBW, net exchangeable cations, chloride, ionised calcium, and pH. The sodium and total calcium concentrations remained at near pre-event values. The PCV, TPP, lactate, potassium, glucose, aspartate aminotransferase, and lactate dehydrogenase activity increased during the Endurance Test, when compared to pre-event values. Horses competing in this competition experienced significant fluid and electrolyte losses, reduced glomerular filtration, increased glycogenolysis and had significant leakage of enzymes from working muscles during competition. These changes could not be reduced by shortening Phase B and lengthening Phase C.

Animals↗
PubMed1995

Physiological responses of horses competing at a modified 1 star 3-day-event.

The impending 1996 summer Olympic 3-day-event in Atlanta has focused attention on the need to determine what modifications to the demanding Endurance Test will be required to ensure safety of the horses competing. Three groups of horses participated in a Field Trial held in August of 1994 in northern Georgia to determine the safety and feasibility of conducting a modified 3-day-event in hot, humid weather. One group (TD) completed a modified 1 Star 3-day-event test, a control group (HT) completed a Horse Trial identical to the modified 1 Star test except for the omission of Phases B and C and the third group (E), comprised of European horses, completed the modified 1 Star test with a longer, faster Phase C than was used for TD. During the Endurance Test, the ambient temperature and relative humidity ranged from 24.3 degrees C and 98.9% in the morning to 30.2 degrees C and 51.6% in the afternoon. No horse failed to complete the Trial because of heat stress or fatigue. There were no significant (P < 0.05) differences detected in heart rate, rectal temperature, respiratory rate or net weight loss between HT and TD horses at any observation time. The highest rectal temperature recorded at the end of Phase C was 39.6 degrees C. These findings suggest that the modified 1 Star Endurance Test was as well tolerated by American horses as the control Horse Trial test. Rectal temperature was significantly higher for E than for TD or HT at the finish of Phase C. European horses had significantly greater decreases in weight than HT and TD at the end of Phases C and D and the next day. These findings probably reflect the faster and longer work effort of E horses during Phase C. Modification of Phase C and the rest-pause to ensure that recovery and heat dissipation occurred before the start of Phase D resulted in a 3-day-event that was safe for horses. The Field Trial provides a model for designing a modified Olympic Endurance Test. If the 1996 Olympic 3-day-event is held in hotter and more humid weather than the Field Trial, additional modifications to the Endurance Test (decreased distances, speeds and numbers of jumping efforts) will probably be required to ensure safety of competing horses.

Animals↗
PubMed1995

Acid:base and serum biochemistry changes in horses competing at a modified 1 Star 3-day-event.

We examined the effects of participation in each of 3 modifications of Day 2 of a 3-day-event on blood and serum variables indicative of hydration, acid:base status and electrolyte homeostasis of horses. Three groups of horses - 8 European (E) horses and 2 groups each of 9 North American horses performed identical Days 1 (dressage) and 3 (stadium jumping) of a 3-day-event. E horses and one group of the North American horses (TD) performed modifications of Day 2 of a 1 Star 3-day-event and the other group of North American horses (HT) performed a Horse Trial on Day 2. Jugular venous blood was collected from each horse on the morning of Day 2 before any warm-up activity, between 4 min 55 s and 5 min 15 s after Phase D and the following morning. Eight E horses, 5 TD horses and 8 HT horses completed the trials. There were few significant differences in acid:base or serum biochemistry variables detected among horses performing either 2 variations of the Speed and Endurance day of a 1 Star 3-day-event, or a conventional Horse Trial. Failure to detect differences among groups may have been related to the low statistical power associated with the small number of horses, especially in the TD group, variation in quality of horses among groups and the different times of the day at which the E horses competed. Differences detected among time points were usually common to all groups and demonstrated metabolic acidosis with a compensatory respiratory alkalosis, a reduction in total body water and cation content, and hypocalcaemia. Importantly, horses of all groups did not replenish cation, chloride, and calcium deficits after 14-18 h of recovery.

Acid-Base Equilibrium↗
PubMed1995

Blood ionized calcium concentrations in horses before and after the cross-country phase of three-day event competition.

Blood ionized calcium (Ca2+) and pH; plasma lactate concentrations; and total protein, total calcium (CaT), albumin, and phosphorus concentrations in serum were determined in 40 healthy horses before (T1), at the finish line (T2), and 10 minutes after the finish (T3) of the cross-country phase of a 3-day-event competition. Mean (+/- SEM) Ca2+ concentrations decreased from 6.22 +/- 0.04 mg/dl at T1 to 5.04 +/- 0.07 mg/dl at T2 (P < or = 0.05). This decrease was accompanied by a nonsignificant increase in CaT between T1 and T2. The mean (+/- SEM) percent ionization of calcium decreased significantly (P < or = 0.05), from 50.9 +/- 2.75% at T1 to 40.3 +/- 3.58% at T2. Significant increases in mean albumin, total protein, phosphorus, and lactate concentrations and a significant decrease in mean pH were observed at T2 (P < or = 0.05). At T3, mean Ca2+ and percent ionization had increased, but remained significantly less than resting values. Mean CaT was significantly decreased at T3, compared with values at T1 and T2. Correlation of mean Ca2+ concentration with all other measured variables at each time was evaluated; correlation coefficients between mean Ca2+ and all other variables were low (r2 < or = 0.38), indicating low biological significance.

Animals↗
PubMed1995

Activation of resident tissue-specific macrophages by swainsonine.

The induction of macrophage tumoricidal activity by swainsonine (8a beta-indolizidine-1 alpha, 2 alpha, 8 beta-triol), an indolizidine alkaloid, has been implicated as possibly an important immune effector mechanism involved in the suppression of tumor growth and metastasis in vital organs such as the lung, liver and spleen (Olden, K. et al. The potential importance of swainsonine in therapy for cancers and immunology. Pharmacol. Ther. 50:285-290; 1991). The present study further explores this possibility by determining whether resident tissue-specific macrophages of several mouse strains can be rendered tumoricidal by systemic administration of swainsonine. We found that systemically administered swainsonine could increase the tumoricidal activity of both alveolar (lung) and splenic macrophages. The activity was enhanced as much as 3- to 4-fold over that obtained with macrophages from organs of control animals and was both dose- and time-dependent. The level and extent of activation by swainsonine was comparable to that achieved with traditional macrophage-activating agents, such as lipopolysaccharide and interferon-gamma. The fact that swainsonine activated highly purified (> 95%) cultures of macrophages from the various sources suggests a direct mechanism of activation. Furthermore, the in vivo activation of macrophages in immune-compromised animals (SCID and nude) lends credence to this suggestion. These findings provide a plausible explanation for the observations that systemically administered swainsonine inhibits organ colonization of metastatic cells and growth of SC tumor xenografts, whereas the growth of tumor cells is not inhibited by swainsonine in culture.

Adjuvants, Immunologic↗
PubMed1994

Weight, water, and cation losses in horses competing in a three-day event.

Body weight of 48 horses competing in a 3-day event was measured the day before the event (baseline), following the dressage phase of the event (day 1), after the endurance phases of the event (day 2), and 18 to 24 hours after the endurance phases (day 3). Plasma sodium and potassium concentrations were measured the evening before, immediately after, and 10 minutes after the endurance phases. Total body water, water loss, and net exchangeable cation loss were then calculated. Body weight and total body water were significantly decreased, compared with baseline values, at all times during the event, and significant water loss was detected. The largest changes were recorded after the endurance phases of the event. Water deficits were still detected 18 to 24 hours after the endurance phases of the event. Mean plasma sodium concentration was significantly increased immediately after the endurance phases of the event, compared with concentration measured the evening before, and remained increased after the 10-minute recovery period, presumably because of dehydration. Mean plasma potassium concentration was significantly increased immediately after the endurance phases of the event, compared with concentration measured the evening before, but was not increased after the 10-minute recovery period.

Animals↗
PubMed1993

Carbonoyloxy analogs of the anti-metastatic drug swainsonine. Activation in tumor cells by esterases.

Swainsonine (SW), a plant alkaloid and inhibitor of alpha-mannosidases, has been shown to inhibit N-linked oligosaccharide processing and to block tumor cell metastasis in mice. In this study, a series of SW analogs were chemically synthesized and compared for inhibition of complex-type N-linked oligosaccharide processing in cultured MDAY-D2 tumor cells, for inhibition of alpha-mannosidases in vitro, and for stimulation of bone marrow proliferation in vivo. Carbonoyloxy substitutions at the 2 and 8 carbons of SW reduced inhibitor activity by 2-3 orders of magnitude for Jack Bean and MDAY-D2 tumor cell lysosomal alpha-mannosidases in vitro. However, 2-p-nitrobenzoyloxy-, 2-octanoyloxy- and 2-butanoyloxy-derivatives of SW retained full activity as inhibitors of Golgi oligosaccharide processing in viable MDAY-D2 tumor cells. Inhibition of oligosaccharide processing was reduced by the esterase inhibitor diethyl p-nitrophenyl phosphate, suggesting that although 2-p-nitrobenzoyloxy-SW, 2-octanoyloxy-SW and 2-butanoyloxy-SW are relatively poor inhibitors of alpha-mannosidases in vitro, the compounds enter cells at a rate comparable to that of SW, and are converted to SW by cellular esterases. The more lipophilic esters, 2-benzoyloxy-SW, 2-toluoyloxy-SW, 8-palmitoyloxy-SW and 8-myristinoyloxy-SW, showed IC50 values at least 10 times higher for inhibition of Golgi oligosaccharide processing, probably due to less efficient entry of the compounds into tumor cells. The anti-metastatic activities of SW and two analogs were tested and shown to correlate with the IC50 values for inhibition of Golgi oligosaccharide processing in cultured tumor cells. In vivo, SW and the analogs were administered intraperitoneally to mice and found to have comparable activities as stimulators of bone marrow cell proliferation. Carbonoyloxy substitutions at the 2- or 8-position of SW with other chemical groups may lead to new drugs with improved pharmacokinetics and anti-cancer activity.

Animals↗
PubMed1993

Clinical evaluation data from a comparative dental implant investigation in dogs.

This report presents one-year clinical evaluation data from 120 ceramic and titanium cylindrical and titanium blade-type implants placed in the mandibles of 30 adult dogs. Ninety-six of the implants supported fixed bridges. The bone and gingival health was evaluated by the following indices: crevicular fluid volume index; gingival bleeding index; plaque accumulation index; clinical mobility index; and a quantitative mobility index utilizing the Periotest instrument. Results from this investigation suggest that, overall, the ceramic implants exhibited more fractures and had more mobile implants than did the titanium implant systems. Overall, complete one-year clinical evaluation data demonstrate healthy tissue responses to 112 of the 120 implants. Further, the Periotest instrument appears to offer a more quantitative assessment of clinical mobility. Also, it appears that the clinical evaluation protocol utilized in this study is a valid procedure to use for the assessment of clinical serviceability.

Analysis of Variance↗
PubMed1992

Ancillary tests for assessment of the nervous system.

This article addresses the minimum data base needed to assist the clinician's diagnostic approach to neurologic diseases. The collection, storage, and processing of cerebrospinal fluid samples are discussed. Additional diagnostic tests are described under selected specific etiologies.

Animals↗
PubMed1992

Assessment of the nervous system.

This article describes the examination of the neurologic and ophthalmic systems in ruminants. Neuroanatomy with respect to lesion localization is reviewed. Pertinent age and species differences are addressed. The practical aspects of assessing the neurologic system are stressed, and the reader is directed to other sources of information for assistance in determining the differential diagnosis and therapy of neurologic disease.

Animals↗
PubMed1992

The Charter Medical Corporation clinical information system: a preliminary report.

Charter Medical Corporation's computerized Clinical Information System is described. The computerized system helps clinicians formulate and document individualized patient treatment plans along the continuum of care and to improve internal medical record keeping. The system can also help improve the efficient collecting, storing, retrieving, and reporting of clinical information, both for internal use and for external utilization review and case management. In the future, the system will be linked to Charter's continuous quality improvement efforts and to its new Clinical Outcome Monitoring System.

Clinical Medicine↗